Euroapotheca v EUIPO - General Nutrition Investment (GNC LIVE WELL) (EU trade mark - Judgment) [2020] EUECJ T-686/19 (08 July 2020)

Euroapotheca v EUIPO - General Nutrition Investment (GNC LIVE WELL) (EU trade mark - Judgment) [2020] EUECJ T-686/19 (08 July 2020)

The Board of Appeal provided sufficient reasoning by reference to both its own and the Cancellation Division's decisions, and the evidence submitted by the intervener, when assessed globally, was sufficient to prove genuine use of the registered mark for the contested goods in the EU during the relevant period. The...

Source-derived case information.

Citation
[2020] EUECJ T-686/19
Parties
Applicant: Euroapotheca UAB; Respondent: European Union Intellectual Property Office (EUIPO); Intervener: General Nutrition Investment Company
Jurisdiction
European Union
Procedural Posture
EU Trade Mark Revocation Appeal / General Court Judgment
Outcome
Action dismissed
Legal Topics
EU Trade Mark Law, Genuine Use, Revocation Proceedings, Evidence Assessment
Intellectual Property EU Trade Mark Law Genuine Use Revocation Proceedings Evidence Assessment

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Downloadable case file Legal principles 4 Authorities cited 33 Party arguments 2 Amounts and remedies 3
Sign in to unlock

Parties

Euroapotheca UAB

Applicant

European Union Intellectual Property Office (EUIPO)

Respondent

General Nutrition Investment Company

Intervener

Procedural Posture

EU Trade Mark Revocation Appeal / General Court Judgment

  1. 1 Whether the Board of Appeal provided adequate reasoning for its decision under Article 94(1) of Regulation 2017/1001
  2. 2 Whether the Board of Appeal correctly assessed the evidence of genuine use of the registered mark for the contested goods under Article 51(1)(a) of Regulation No 207/2009

Ratio Decidendi

The Board of Appeal provided sufficient reasoning by reference to both its own and the Cancellation Division's decisions, and the evidence submitted by the intervener, when assessed globally, was sufficient to prove genuine use of the registered mark for the contested goods in the EU during the relevant period. The applicant's arguments regarding insufficiency of evidence, alteration of distinctive character, and procedural irregularities were rejected.

Court Disposition

Action dismissed

Orders

  • Euroapotheca UAB to pay the costs